![Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5 - Juraszek - 2021 - Journal of Neurochemistry - Wiley Online Library Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5 - Juraszek - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/017971ff-0569-422d-850a-2295b282c9ce/jnc15124-fig-0008-m.png)
Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5 - Juraszek - 2021 - Journal of Neurochemistry - Wiley Online Library
![Functional Genetic Diversity in the High-Affinity Carnitine Transporter OCTN2 (SLC22A5) | Molecular Pharmacology Functional Genetic Diversity in the High-Affinity Carnitine Transporter OCTN2 (SLC22A5) | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/70/5/1602/F1.large.jpg)
Functional Genetic Diversity in the High-Affinity Carnitine Transporter OCTN2 (SLC22A5) | Molecular Pharmacology
![Molecules | Free Full-Text | SLC22A5 (OCTN2) Carnitine Transporter—Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer Molecules | Free Full-Text | SLC22A5 (OCTN2) Carnitine Transporter—Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer](https://pub.mdpi-res.com/molecules/molecules-25-00014/article_deploy/html/images/molecules-25-00014-ag-550.jpg?1579223157)
Molecules | Free Full-Text | SLC22A5 (OCTN2) Carnitine Transporter—Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer
![Frontiers | Newborn Screening and Genetic Analysis Identify Six Novel Genetic Variants for Primary Carnitine Deficiency in Ningbo Area, China Frontiers | Newborn Screening and Genetic Analysis Identify Six Novel Genetic Variants for Primary Carnitine Deficiency in Ningbo Area, China](https://www.frontiersin.org/files/MyHome%20Article%20Library/686137/686137_Thumb_400.jpg)
Frontiers | Newborn Screening and Genetic Analysis Identify Six Novel Genetic Variants for Primary Carnitine Deficiency in Ningbo Area, China
![Maternal systemic primary carnitine deficiency uncovered by newborn screening: Clinical, biochemical, and molecular aspects | Genetics in Medicine Maternal systemic primary carnitine deficiency uncovered by newborn screening: Clinical, biochemical, and molecular aspects | Genetics in Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1097%2FGIM.0b013e3181c5e6f7/MediaObjects/41436_2010_Article_BFgim20103_Fig1_HTML.jpg)
Maternal systemic primary carnitine deficiency uncovered by newborn screening: Clinical, biochemical, and molecular aspects | Genetics in Medicine
![PDF] 20 Years After Discovery of the Causative Gene of Primary Carnitine Deficiency, How Much More Have We Known About the Disease? | Semantic Scholar PDF] 20 Years After Discovery of the Causative Gene of Primary Carnitine Deficiency, How Much More Have We Known About the Disease? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/651ba513a258b0a57dc15c728599dfc387fb11ea/3-Figure1-1.png)
PDF] 20 Years After Discovery of the Causative Gene of Primary Carnitine Deficiency, How Much More Have We Known About the Disease? | Semantic Scholar
![A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features | BMC Cardiovascular Disorders | Full Text A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features | BMC Cardiovascular Disorders | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12872-023-03676-z/MediaObjects/12872_2023_3676_Fig1_HTML.png)
A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features | BMC Cardiovascular Disorders | Full Text
![Frontiers | Biochemical, Molecular, and Clinical Characterization of Patients With Primary Carnitine Deficiency via Large-Scale Newborn Screening in Xuzhou Area Frontiers | Biochemical, Molecular, and Clinical Characterization of Patients With Primary Carnitine Deficiency via Large-Scale Newborn Screening in Xuzhou Area](https://www.frontiersin.org/files/Articles/429427/fped-07-00050-HTML/image_m/fped-07-00050-g005.jpg)
Frontiers | Biochemical, Molecular, and Clinical Characterization of Patients With Primary Carnitine Deficiency via Large-Scale Newborn Screening in Xuzhou Area
![The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase - ScienceDirect The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003986123001157-ga1.jpg)